Well Referenced

Tag: antisense therapy

Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes

This review article discusses the clinical significance of lipoprotein(a) [Lp(a)] as an independent risk factor for cardiovascular diseases, including coronary artery disease and calcific aortic valve disease. It highlights that Lp(a) levels are genetically determined and remain constant throughout life. The article emphasizes the importance of measuring Lp(a) levels for

Read More »
June 26, 2025 No Comments

Lipoprotein(a) and Cardiovascular Disease: A Missing Link for Premature Atherosclerotic Heart Disease and/or Residual Risk

This comprehensive review highlights lipoprotein(a) [Lp(a)] as a genetically determined, independent risk factor for various cardiovascular diseases, including coronary artery disease, aortic valve stenosis, ischemic stroke, heart failure, and peripheral arterial disease. Elevated Lp(a) levels (≥50 mg/dL or ≥100 nmol/L) are prevalent in approximately 20% of the population and contribute

Read More »
June 26, 2025 No Comments